Cardiometabolic Diseases Market Opportunities Across Prevention and Treatment Segments
The competitive landscape of the global metabolic therapeutics sector is experiencing rapid changes as massive patent expirations loom for several blockbuster small-molecule drugs. This upcoming wave of patent cliffs is pushing major pharmaceutical firms to aggressively shift their capital allocations away from traditional chemical synthesis and toward complex, high-margin biopharmaceuticals....
0 Commentaires 0 Parts 183 Vue 0 Aperçu